| Name | Simtuzumab |
|---|
| Description | Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C7H6BClO4 |
|---|---|
| Molecular Weight | 200.38 |
| Exact Mass | 200.0047665 |